|
Neurocognitive implications of cannabidiol (CBD) while aging with HIV |
1R03DA057146-01 |
|
NIDA |
2022 |
|
A telehealth tDCS approach to decrease cannabis use: Towards reducing multiple sclerosis disability in multiple sclerosis |
1R21DA055427-01 |
|
NIDA |
2022 |
|
Psychostimulants, Attention Deficit and Basal Ganglia Disorders |
1R21DA055980-01 |
|
NIDA |
2022 |
|
Dissecting functional roles of MeCP2 condensates in neurons with chemogenetic tools |
1R21DA056293-01 |
|
NIDA |
2022 |
|
Leveraging ΔFosB as a potential therapeutic for Alzheimers Disease |
3R01DA040621-07S1 |
|
NIDA |
2022 |
|
Neuroepigenetic mechanisms of chronic low back pain using histone deacetylases PET imaging |
4R33DA048485-03 |
|
NIDA |
2022 |
|
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo |
5R01DA045596-05 |
|
NIDA |
2022 |
|
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection |
1 R01 DA052845-01 |
MOHAN, MAHESH |
NIDA |
2020 |
|
1/2 - Anomalous Motor System Physiology in ADHD: Biomarker Validation and Modeling Domains of Function |
2R01MH095014-06 |
GILBERT, DONALD L |
NIDA |
2020 |
|
1/2 - Anomalous Motor System Physiology in ADHD: Biomarker Validation and Modeling Domains of Function |
2R01MH095014-06 |
GILBERT, DONALD L |
NIDA |
2020 |